Project Coordinator Michael Hudecek will represent #T2EVOLVE alongside Maik Luu and Dirk Busch at ASGCT’s Spotlight on Immuno-Oncology Conference on August 1-2.

The event features speakers and topics including novel CAR designs and approaches beyond B-Cell malignancies, genome and epigenome editing, and direct in vivo delivery for cancer immunotherapy.

Learn more about the meeting at:

Share This